getting too vocal with the gatekeepers is akin to a parents' brawl at a kids soccer match. stupid, immature and childish. "fun" but costly. and gets you nowhere but light years from where you want to be.
the pros are handling the data, and the data is the ONLY thing that matters. let them do their job, you wouldnt want some antsy karen interfering with your job at your office now would you. once the finish line has been crossed, let the i -told-you-so marketing parade begin, not before.
dont want to sound like the ivermectin crowd now do we.
my form of protest costs .26 each
Quote:"I would vote for stepping things up a bit. Maybe that edited Charlie Sheen video and a major PR campaign with PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative Breast Cancer focus."
You really think your "stepping things up" is going to persuade a BP into a partnership/buyout? You think it's going make the FDA say "whoa, look at the wonders of LL in Charlie Sheen's video and that under powered mTNBC trial"? In my opinion, based on my view of our history, such cheap promotions haven't significantly changed things with potential shareholders either and are highly unlikely to do so now, or in the future, without serious supporting data. To me, and I'm just a novice at all of this, it's ALL about the data produced by a clean, well constructed, trial. Data, data, data! The mCRC trial appears to me to potentially be a quality attention getter, depending on LL's performance. I have some significant confidence in LL, but we shall see.